These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12096231)

  • 1. Selective COX-2 inhibition prevents proinflammatory cytokine-induced cartilage damage.
    Mastbergen SC; Lafeber FP; Bijlsma JW
    Rheumatology (Oxford); 2002 Jul; 41(7):801-8. PubMed ID: 12096231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and release of human cartilage matrix proteoglycans are differently regulated by nitric oxide and prostaglandin-E2.
    Mastbergen SC; Bijlsma JW; Lafeber FP
    Ann Rheum Dis; 2008 Jan; 67(1):52-8. PubMed ID: 17485421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in vitro study.
    Mastbergen SC; Bijlsma JW; Lafeber FP
    Osteoarthritis Cartilage; 2005 Jun; 13(6):519-26. PubMed ID: 15922186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase inhibitor CGS 27023A protects COMP and proteoglycan in the bovine articular cartilage but not the release of their fragments from cartilage after prolonged stimulation in vitro with IL-1 alpha.
    Ganu V; Melton R; Wang W; Roberts D
    Ann N Y Acad Sci; 1999 Jun; 878():607-11. PubMed ID: 10415786
    [No Abstract]   [Full Text] [Related]  

  • 5. The chondroprotective effect of selective COX-2 inhibition in osteoarthritis: ex vivo evaluation of human cartilage tissue after in vivo treatment.
    de Boer TN; Huisman AM; Polak AA; Niehoff AG; van Rinsum AC; Saris D; Bijlsma JW; Lafeber FJ; Mastbergen SC
    Osteoarthritis Cartilage; 2009 Apr; 17(4):482-8. PubMed ID: 18926729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study.
    Mastbergen SC; Jansen NW; Bijlsma JW; Lafeber FP
    Arthritis Res Ther; 2006; 8(1):R2. PubMed ID: 16356188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis.
    Alvarez-Soria MA; Herrero-Beaumont G; Moreno-Rubio J; Calvo E; Santillana J; Egido J; Largo R
    Osteoarthritis Cartilage; 2008 Dec; 16(12):1484-93. PubMed ID: 18547825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase inhibition lowers prostaglandin E2 release from articular cartilage and reduces apoptosis but not proteoglycan degradation following an impact load in vitro.
    Jeffrey JE; Aspden RM
    Arthritis Res Ther; 2007; 9(6):R129. PubMed ID: 18096078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-4 alone and in combination with IL-10 protects against blood-induced cartilage damage.
    van Meegeren ME; Roosendaal G; Jansen NW; Wenting MJ; van Wesel AC; van Roon JA; Lafeber FP
    Osteoarthritis Cartilage; 2012 Jul; 20(7):764-72. PubMed ID: 22503813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Phellodendron amurense in protecting human osteoarthritic cartilage and chondrocytes.
    Kim JH; Huh JE; Baek YH; Lee JD; Choi DY; Park DS
    J Ethnopharmacol; 2011 Mar; 134(2):234-42. PubMed ID: 21182922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
    Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
    Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
    Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
    Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of cyclo-oxygenase-2 inhibitor on the production of matrix metalloproteinases in rheumatoid fibroblast-like synoviocytes.
    Cha HS; Ahn KS; Jeon CH; Kim J; Koh EM
    Rheumatol Int; 2004 Jul; 24(4):207-11. PubMed ID: 12898179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib has a positive effect on the overall metabolism of hyaluronan and proteoglycans in human osteoarthritic cartilage.
    El Hajjaji H; Marcelis A; Devogelaer JP; Manicourt DH
    J Rheumatol; 2003 Nov; 30(11):2444-51. PubMed ID: 14677191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib does not affect the release of hyaluronic acid in end stage osteoarthritic joints.
    Takahashi D; Majima T; Onodera T; Kasahara Y; Inoue M; Irie T; Kasemura T
    Mod Rheumatol; 2013 Sep; 23(5):934-8. PubMed ID: 23001685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis.
    Mastbergen SC; Marijnissen AC; Vianen ME; Zoer B; van Roermund PM; Bijlsma JW; Lafeber FP
    Rheumatology (Oxford); 2006 Apr; 45(4):405-13. PubMed ID: 16287921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor.
    Alsalameh S; Mattka B; Al-Ward R; Lorenz HM; Manger B; Pfizenmaier K; Grell M; Kalden JR
    J Rheumatol; 1999 Mar; 26(3):645-53. PubMed ID: 10090177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative and combined effects of interleukin 6, interleukin 1 beta, and tumor necrosis factor alpha on proteoglycan metabolism of human articular chondrocytes cultured in agarose.
    Malfait AM; Verbruggen G; Veys EM; Lambert J; De Ridder L; Cornelissen M
    J Rheumatol; 1994 Feb; 21(2):314-20. PubMed ID: 8182643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of Celecoxib on matrix synthesis by chondrocytes under mechanical stress in vitro.
    Iimoto S; Watanabe S; Takahashi T; Shimizu A; Yamamoto H
    Int J Mol Med; 2005 Dec; 16(6):1083-8. PubMed ID: 16273290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: interaction with exogenous cytokines.
    Patwari P; Cook MN; DiMicco MA; Blake SM; James IE; Kumar S; Cole AA; Lark MW; Grodzinsky AJ
    Arthritis Rheum; 2003 May; 48(5):1292-301. PubMed ID: 12746902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.